Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Kurumsal BaşvuruSign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Kurumsal Başvuru

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Contact

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2026 Raw Data Library. All rights reserved.
PrivacyTermsContact
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Article
en
2023

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

0 Datasets

0 Files

en
2023
Vol 389 (13)
Vol. 389
DOI: 10.1056/nejmoa2303062

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Professor Gregory Lip
Professor Gregory Lip

University of Liverpool

Verified
Paulus Kirchhof
Tobias Toennis
Andreas Goette
+31 more

Abstract

Among patients with AHREs detected by implantable devices, anticoagulation with edoxaban did not significantly reduce the incidence of a composite of cardiovascular death, stroke, or systemic embolism as compared with placebo, but it led to a higher incidence of a composite of death or major bleeding. The incidence of stroke was low in both groups. (Funded by the German Center for Cardiovascular Research and others; NOAH-AFNET 6 ClinicalTrials.gov number, NCT02618577; ISRCTN number, ISRCTN17309850.).

How to cite this publication

Paulus Kirchhof, Tobias Toennis, Andreas Goette, A. John Camm, Hans‐Christoph Diener, Nina Becher, Emanuele Bertaglia, Carina Blomström Lundqvist, Martin Borlich, Axel Brandes, Nuno Cabanelas, Melanie Calvert, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Joris R. de Groot, Wolfgang Dichtl, Borys B. Kravchuk, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Douglas S. Scherr, Rafał Sznajder, Vasil Velchev, Dan Wichterle, Susanne Sehner, Εmmanuel Simantirakis, Professor Gregory Lip, Panos Vardas, Ulrich Schotten, Antonia Zapf (2023). Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. , 389(13), DOI: https://doi.org/10.1056/nejmoa2303062.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Article

Year

2023

Authors

34

Datasets

0

Total Files

0

Language

en

DOI

https://doi.org/10.1056/nejmoa2303062

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access